APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alzheimer’s Therapeutic

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Alzheimer’s Therapeutic Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchAlzheimer’s Therapeutic Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Alzheimer’s Therapeutic Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Alzheimer’s Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alzheimer’s Therapeutic Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Alzheimer’s Therapeutic Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Alzheimer’s Therapeutic market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alzheimer’s Therapeutic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Alzheimer’s Therapeutic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Alzheimer’s Therapeutic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Alzheimer’s Therapeutic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Alzheimer’s Therapeutic include Takeda Pharmaceutical Company Ltd, Merck & Co, F. Hoffman Le Roche, Eli Lilly, Inc, Pfizer Inc, Novartis International AG, H. Lundbeck A/S, Biotie Therapies and Axovant Sciences Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Alzheimer’s Therapeutic, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Alzheimer’s Therapeutic, also provides the sales of main regions and countries. Of the upcoming market potential for Alzheimer’s Therapeutic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alzheimer’s Therapeutic sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alzheimer’s Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Alzheimer’s Therapeutic sales, projected growth trends, production technology, application and end-user industry.

Alzheimer’s Therapeutic Segment by Company

Takeda Pharmaceutical Company Ltd

Merck & Co

F. Hoffman Le Roche

Eli Lilly, Inc

Pfizer Inc

Novartis International AG

H. Lundbeck A/S

Biotie Therapies

Axovant Sciences Ltd

Astra Zeneca plc

Acadia Pharmaceuticals, Inc

Alzheimer’s Therapeutic Segment by Type

Rivastigmine

Galantamine Hydrobromide

Donepezil Hydrochloride

Memantine Hydrochloride

Alzheimer’s Therapeutic Segment by Application

Hospitals

Clinic

Other

Alzheimer’s Therapeutic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alzheimer’s Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alzheimer’s Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alzheimer’s Therapeutic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Alzheimer’s Therapeutic in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Alzheimer’s Therapeutic manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alzheimer’s Therapeutic sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alzheimer’s Therapeutic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rivastigmine Major Manufacturers Table 3. Galantamine Hydrobromide Major Manufacturers Table 4. Donepezil Hydrochloride Major Manufacturers Table 5. Memantine Hydrochloride Major Manufacturers Table 6. Global Alzheimer’s Therapeutic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Other Major Manufacturers Table 10. Alzheimer’s Therapeutic Industry Trends Table 11. Alzheimer’s Therapeutic Industry Drivers Table 12. Alzheimer’s Therapeutic Industry Opportunities and Challenges Table 13. Alzheimer’s Therapeutic Industry Restraints Table 14. Global Alzheimer’s Therapeutic Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Alzheimer’s Therapeutic Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Alzheimer’s Therapeutic Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Alzheimer’s Therapeutic Revenue Market Share by Region (2021-2026) Table 18. Global Alzheimer’s Therapeutic Revenue Market Share by Region (2027-2032) Table 19. Global Alzheimer’s Therapeutic Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Alzheimer’s Therapeutic Sales by Region (2021-2026) & (k units) Table 21. Global Alzheimer’s Therapeutic Sales by Region (2027-2032) & (k units) Table 22. Global Alzheimer’s Therapeutic Sales Market Share by Region (2021-2026) Table 23. Global Alzheimer’s Therapeutic Sales Market Share by Region (2027-2032) Table 24. Global Alzheimer’s Therapeutic Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Alzheimer’s Therapeutic Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Alzheimer’s Therapeutic Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Alzheimer’s Therapeutic Sales Market Share by Manufacturers (2021-2026) Table 28. Global Alzheimer’s Therapeutic Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Alzheimer’s Therapeutic Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Alzheimer’s Therapeutic Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Alzheimer’s Therapeutic Manufacturers, Product Type & Application Table 32. Global Alzheimer’s Therapeutic Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Alzheimer’s Therapeutic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Alzheimer’s Therapeutic Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Alzheimer’s Therapeutic Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Alzheimer’s Therapeutic Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2021-2026) Table 39. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2027-2032) Table 40. Global Alzheimer’s Therapeutic Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 42. Global Alzheimer’s Therapeutic Sales by Type (2027-2032) & (k units) Table 43. Global Alzheimer’s Therapeutic Sales Market Share by Type (2021-2026) Table 44. Global Alzheimer’s Therapeutic Sales Market Share by Type (2027-2032) Table 45. Global Alzheimer’s Therapeutic Price by Type (2021-2026) & (US$/unit) Table 46. Global Alzheimer’s Therapeutic Price by Type (2027-2032) & (US$/unit) Table 47. Global Alzheimer’s Therapeutic Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Alzheimer’s Therapeutic Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Alzheimer’s Therapeutic Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2021-2026) Table 51. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2027-2032) Table 52. Global Alzheimer’s Therapeutic Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 54. Global Alzheimer’s Therapeutic Sales by Application (2027-2032) & (k units) Table 55. Global Alzheimer’s Therapeutic Sales Market Share by Application (2021-2026) Table 56. Global Alzheimer’s Therapeutic Sales Market Share by Application (2027-2032) Table 57. Global Alzheimer’s Therapeutic Price by Application (2021-2026) & (US$/unit) Table 58. Global Alzheimer’s Therapeutic Price by Application (2027-2032) & (US$/unit) Table 59. Takeda Pharmaceutical Company Ltd Company Information Table 60. Takeda Pharmaceutical Company Ltd Business Overview Table 61. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product Portfolio Table 63. Takeda Pharmaceutical Company Ltd Recent Development Table 64. Merck & Co Company Information Table 65. Merck & Co Business Overview Table 66. Merck & Co Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Merck & Co Alzheimer’s Therapeutic Product Portfolio Table 68. Merck & Co Recent Development Table 69. F. Hoffman Le Roche Company Information Table 70. F. Hoffman Le Roche Business Overview Table 71. F. Hoffman Le Roche Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. F. Hoffman Le Roche Alzheimer’s Therapeutic Product Portfolio Table 73. F. Hoffman Le Roche Recent Development Table 74. Eli Lilly, Inc Company Information Table 75. Eli Lilly, Inc Business Overview Table 76. Eli Lilly, Inc Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Eli Lilly, Inc Alzheimer’s Therapeutic Product Portfolio Table 78. Eli Lilly, Inc Recent Development Table 79. Pfizer Inc Company Information Table 80. Pfizer Inc Business Overview Table 81. Pfizer Inc Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Pfizer Inc Alzheimer’s Therapeutic Product Portfolio Table 83. Pfizer Inc Recent Development Table 84. Novartis International AG Company Information Table 85. Novartis International AG Business Overview Table 86. Novartis International AG Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Novartis International AG Alzheimer’s Therapeutic Product Portfolio Table 88. Novartis International AG Recent Development Table 89. H. Lundbeck A/S Company Information Table 90. H. Lundbeck A/S Business Overview Table 91. H. Lundbeck A/S Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. H. Lundbeck A/S Alzheimer’s Therapeutic Product Portfolio Table 93. H. Lundbeck A/S Recent Development Table 94. Biotie Therapies Company Information Table 95. Biotie Therapies Business Overview Table 96. Biotie Therapies Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Biotie Therapies Alzheimer’s Therapeutic Product Portfolio Table 98. Biotie Therapies Recent Development Table 99. Axovant Sciences Ltd Company Information Table 100. Axovant Sciences Ltd Business Overview Table 101. Axovant Sciences Ltd Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Axovant Sciences Ltd Alzheimer’s Therapeutic Product Portfolio Table 103. Axovant Sciences Ltd Recent Development Table 104. Astra Zeneca plc Company Information Table 105. Astra Zeneca plc Business Overview Table 106. Astra Zeneca plc Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Astra Zeneca plc Alzheimer’s Therapeutic Product Portfolio Table 108. Astra Zeneca plc Recent Development Table 109. Acadia Pharmaceuticals, Inc Company Information Table 110. Acadia Pharmaceuticals, Inc Business Overview Table 111. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product Portfolio Table 113. Acadia Pharmaceuticals, Inc Recent Development Table 114. North America Alzheimer’s Therapeutic Revenue by Type (2021-2026) & (US$ Million) Table 115. North America Alzheimer’s Therapeutic Revenue by Type (2027-2032) & (US$ Million) Table 116. North America Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 117. North America Alzheimer’s Therapeutic Sales by Type (2027-2032) & (k units) Table 118. North America Alzheimer’s Therapeutic Sales Price by Type (2021-2026) & (US$/unit) Table 119. North America Alzheimer’s Therapeutic Sales Price by Type (2027-2032) & (US$/unit) Table 120. North America Alzheimer’s Therapeutic Revenue by Application (2021-2026) & (US$ Million) Table 121. North America Alzheimer’s Therapeutic Revenue by Application (2027-2032) & (US$ Million) Table 122. North America Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 123. North America Alzheimer’s Therapeutic Sales by Application (2027-2032) & (k units) Table 124. North America Alzheimer’s Therapeutic Sales Price by Application (2021-2026) & (US$/unit) Table 125. North America Alzheimer’s Therapeutic Sales Price by Application (2027-2032) & (US$/unit) Table 126. North America Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. North America Alzheimer’s Therapeutic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. North America Alzheimer’s Therapeutic Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 130. North America Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 131. North America Alzheimer’s Therapeutic Sales by Country (2027-2032) & (k units) Table 132. North America Alzheimer’s Therapeutic Sales Price by Country (2021-2026) & (US$/unit) Table 133. North America Alzheimer’s Therapeutic Sales Price by Country (2027-2032) & (US$/unit) Table 134. United States Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 135. Canada Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 136. Mexico Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 137. Europe Alzheimer’s Therapeutic Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Alzheimer’s Therapeutic Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 140. Europe Alzheimer’s Therapeutic Sales by Type (2027-2032) & (k units) Table 141. Europe Alzheimer’s Therapeutic Sales Price by Type (2021-2026) & (US$/unit) Table 142. Europe Alzheimer’s Therapeutic Sales Price by Type (2027-2032) & (US$/unit) Table 143. Europe Alzheimer’s Therapeutic Revenue by Application (2021-2026) & (US$ Million) Table 144. Europe Alzheimer’s Therapeutic Revenue by Application (2027-2032) & (US$ Million) Table 145. Europe Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 146. Europe Alzheimer’s Therapeutic Sales by Application (2027-2032) & (k units) Table 147. Europe Alzheimer’s Therapeutic Sales Price by Application (2021-2026) & (US$/unit) Table 148. Europe Alzheimer’s Therapeutic Sales Price by Application (2027-2032) & (US$/unit) Table 149. Europe Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Europe Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Europe Alzheimer’s Therapeutic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Europe Alzheimer’s Therapeutic Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 153. Europe Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 154. Europe Alzheimer’s Therapeutic Sales by Country (2027-2032) & (k units) Table 155. Europe Alzheimer’s Therapeutic Sales Price by Country (2021-2026) & (US$/unit) Table 156. Europe Alzheimer’s Therapeutic Sales Price by Country (2027-2032) & (US$/unit) Table 157. Germany Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 158. France Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 159. U.K. Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 160. Italy Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 161. Russia Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 162. Spain Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 163. Netherlands Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 164. Switzerland Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 165. Sweden Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 166. Poland Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 167. China Alzheimer’s Therapeutic Revenue by Type (2021-2026) & (US$ Million) Table 168. China Alzheimer’s Therapeutic Revenue by Type (2027-2032) & (US$ Million) Table 169. China Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 170. China Alzheimer’s Therapeutic Sales by Type (2027-2032) & (k units) Table 171. China Alzheimer’s Therapeutic Sales Price by Type (2021-2026) & (US$/unit) Table 172. China Alzheimer’s Therapeutic Sales Price by Type (2027-2032) & (US$/unit) Table 173. China Alzheimer’s Therapeutic Revenue by Application (2021-2026) & (US$ Million) Table 174. China Alzheimer’s Therapeutic Revenue by Application (2027-2032) & (US$ Million) Table 175. China Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 176. China Alzheimer’s Therapeutic Sales by Application (2027-2032) & (k units) Table 177. China Alzheimer’s Therapeutic Sales Price by Application (2021-2026) & (US$/unit) Table 178. China Alzheimer’s Therapeutic Sales Price by Application (2027-2032) & (US$/unit) Table 179. Asia Alzheimer’s Therapeutic Revenue by Type (2021-2026) & (US$ Million) Table 180. Asia Alzheimer’s Therapeutic Revenue by Type (2027-2032) & (US$ Million) Table 181. Asia Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 182. Asia Alzheimer’s Therapeutic Sales by Type (2027-2032) & (k units) Table 183. Asia Alzheimer’s Therapeutic Sales Price by Type (2021-2026) & (US$/unit) Table 184. Asia Alzheimer’s Therapeutic Sales Price by Type (2027-2032) & (US$/unit) Table 185. Asia Alzheimer’s Therapeutic Revenue by Application (2021-2026) & (US$ Million) Table 186. Asia Alzheimer’s Therapeutic Revenue by Application (2027-2032) & (US$ Million) Table 187. Asia Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 188. Asia Alzheimer’s Therapeutic Sales by Application (2027-2032) & (k units) Table 189. Asia Alzheimer’s Therapeutic Sales Price by Application (2021-2026) & (US$/unit) Table 190. Asia Alzheimer’s Therapeutic Sales Price by Application (2027-2032) & (US$/unit) Table 191. Asia Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Asia Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. Asia Alzheimer’s Therapeutic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. Asia Alzheimer’s Therapeutic Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 195. Asia Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 196. Asia Alzheimer’s Therapeutic Sales by Country (2027-2032) & (k units) Table 197. Asia Alzheimer’s Therapeutic Sales Price by Country (2021-2026) & (US$/unit) Table 198. Asia Alzheimer’s Therapeutic Sales Price by Country (2027-2032) & (US$/unit) Table 199. Japan Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 200. South Korea Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 201. India Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 202. Australia Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 203. Taiwan Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 204. Southeast Asia Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 205. SAMEA Alzheimer’s Therapeutic Revenue by Type (2021-2026) & (US$ Million) Table 206. SAMEA Alzheimer’s Therapeutic Revenue by Type (2027-2032) & (US$ Million) Table 207. SAMEA Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 208. SAMEA Alzheimer’s Therapeutic Sales by Type (2027-2032) & (k units) Table 209. SAMEA Alzheimer’s Therapeutic Sales Price by Type (2021-2026) & (US$/unit) Table 210. SAMEA Alzheimer’s Therapeutic Sales Price by Type (2027-2032) & (US$/unit) Table 211. SAMEA Alzheimer’s Therapeutic Revenue by Application (2021-2026) & (US$ Million) Table 212. SAMEA Alzheimer’s Therapeutic Revenue by Application (2027-2032) & (US$ Million) Table 213. SAMEA Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 214. SAMEA Alzheimer’s Therapeutic Sales by Application (2027-2032) & (k units) Table 215. SAMEA Alzheimer’s Therapeutic Sales Price by Application (2021-2026) & (US$/unit) Table 216. SAMEA Alzheimer’s Therapeutic Sales Price by Application (2027-2032) & (US$/unit) Table 217. SAMEA Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. SAMEA Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. SAMEA Alzheimer’s Therapeutic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. SAMEA Alzheimer’s Therapeutic Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 221. SAMEA Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 222. SAMEA Alzheimer’s Therapeutic Sales by Country (2027-2032) & (k units) Table 223. SAMEA Alzheimer’s Therapeutic Sales Price by Country (2021-2026) & (US$/unit) Table 224. SAMEA Alzheimer’s Therapeutic Sales Price by Country (2027-2032) & (US$/unit) Table 225. Brazil Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 226. Argentina Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 227. Chile Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 228. Colombia Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 229. Peru Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 230. Saudi Arabia Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 231. Israel Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 232. UAE Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 233. Turkey Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 234. Iran Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 235. Egypt Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Table 236. Key Raw Materials Table 237. Raw Materials Key Suppliers Table 238. Alzheimer’s Therapeutic Distributors List Table 239. Alzheimer’s Therapeutic Customers List Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Alzheimer’s Therapeutic Image Figure 2. Global Alzheimer’s Therapeutic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alzheimer’s Therapeutic Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rivastigmine Image Figure 5. Galantamine Hydrobromide Image Figure 6. Donepezil Hydrochloride Image Figure 7. Memantine Hydrochloride Image Figure 8. Global Alzheimer’s Therapeutic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Alzheimer’s Therapeutic Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Clinic Image Figure 12. Other Image Figure 13. Global Alzheimer’s Therapeutic Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Figure 15. Global Alzheimer’s Therapeutic Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Alzheimer’s Therapeutic Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Alzheimer’s Therapeutic Revenue Market Share by Region (2021-2032) Figure 18. Global Alzheimer’s Therapeutic Sales (2021-2032) & (k units) Figure 19. Global Alzheimer’s Therapeutic Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Alzheimer’s Therapeutic Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Alzheimer’s Therapeutic Sales YoY (2021-2032) & (k units) Figure 22. Europe Alzheimer’s Therapeutic Sales YoY (2021-2032) & (k units) Figure 23. China Alzheimer’s Therapeutic Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Alzheimer’s Therapeutic Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Alzheimer’s Therapeutic Sales YoY (2021-2032) & (k units) Figure 26. Global Alzheimer’s Therapeutic Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Alzheimer’s Therapeutic Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Alzheimer’s Therapeutic Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Alzheimer’s Therapeutic Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2021-2032) Figure 32. Global Alzheimer’s Therapeutic Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Alzheimer’s Therapeutic Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Alzheimer’s Therapeutic Sales Market Share by Type (2021-2032) Figure 35. Global Alzheimer’s Therapeutic Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Alzheimer’s Therapeutic Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2021-2032) Figure 38. Global Alzheimer’s Therapeutic Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Alzheimer’s Therapeutic Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Alzheimer’s Therapeutic Sales Market Share by Application (2021-2032) Figure 41. North America Alzheimer’s Therapeutic Revenue Share by Type (2021-2032) Figure 42. North America Alzheimer’s Therapeutic Sales Share by Type (2021-2032) Figure 43. North America Alzheimer’s Therapeutic Revenue Share by Application (2021-2032) Figure 44. North America Alzheimer’s Therapeutic Sales Share by Application (2021-2032) Figure 45. North America Alzheimer’s Therapeutic Revenue Share by Country (2021-2032) Figure 46. North America Alzheimer’s Therapeutic Sales Share by Country (2021-2032) Figure 47. Europe Alzheimer’s Therapeutic Revenue Share by Type (2021-2032) Figure 48. Europe Alzheimer’s Therapeutic Sales Share by Type (2021-2032) Figure 49. Europe Alzheimer’s Therapeutic Revenue Share by Application (2021-2032) Figure 50. Europe Alzheimer’s Therapeutic Sales Share by Application (2021-2032) Figure 51. Europe Alzheimer’s Therapeutic Revenue Share by Country (2021-2032) Figure 52. Europe Alzheimer’s Therapeutic Sales Share by Country (2021-2032) Figure 53. China Alzheimer’s Therapeutic Revenue Share by Type (2021-2032) Figure 54. China Alzheimer’s Therapeutic Sales Share by Type (2021-2032) Figure 55. China Alzheimer’s Therapeutic Revenue Share by Application (2021-2032) Figure 56. China Alzheimer’s Therapeutic Sales Share by Application (2021-2032) Figure 57. Asia Alzheimer’s Therapeutic Revenue Share by Type (2021-2032) Figure 58. Asia Alzheimer’s Therapeutic Sales Share by Type (2021-2032) Figure 59. Asia Alzheimer’s Therapeutic Revenue Share by Application (2021-2032) Figure 60. Asia Alzheimer’s Therapeutic Sales Share by Application (2021-2032) Figure 61. Asia Alzheimer’s Therapeutic Revenue Share by Country (2021-2032) Figure 62. Asia Alzheimer’s Therapeutic Sales Share by Country (2021-2032) Figure 63. SAMEA Alzheimer’s Therapeutic Revenue Share by Type (2021-2032) Figure 64. SAMEA Alzheimer’s Therapeutic Sales Share by Type (2021-2032) Figure 65. SAMEA Alzheimer’s Therapeutic Revenue Share by Application (2021-2032) Figure 66. SAMEA Alzheimer’s Therapeutic Sales Share by Application (2021-2032) Figure 67. SAMEA Alzheimer’s Therapeutic Revenue Share by Country (2021-2032) Figure 68. SAMEA Alzheimer’s Therapeutic Sales Share by Country (2021-2032) Figure 69. Alzheimer’s Therapeutic Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Alzheimer’s Therapeutic Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Rivastigmine
  • Galantamine Hydrobromide
  • Donepezil Hydrochloride
  • Memantine Hydrochloride
Applications
  • Hospitals
  • Clinic
  • Other
Companies covered
  • Takeda Pharmaceutical Company Ltd
  • Merck & Co
  • F. Hoffman Le Roche
  • Eli Lilly, Inc
  • Pfizer Inc
  • Novartis International AG
  • H. Lundbeck A/S
  • Biotie Therapies
  • Axovant Sciences Ltd
  • Astra Zeneca plc
  • Acadia Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alzheimer’s Therapeutic Market by Type
  3. 1.2.1 Global Alzheimer’s Therapeutic Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rivastigmine
  5. 1.2.3 Galantamine Hydrobromide
  6. 1.2.4 Donepezil Hydrochloride
  7. 1.2.5 Memantine Hydrochloride
  8. 1.3 Alzheimer’s Therapeutic Market by Application
  9. 1.3.1 Global Alzheimer’s Therapeutic Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Clinic
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Alzheimer’s Therapeutic Market Dynamics
  1. 2.1 Alzheimer’s Therapeutic Industry Trends
  2. 2.2 Alzheimer’s Therapeutic Industry Drivers
  3. 2.3 Alzheimer’s Therapeutic Industry Opportunities and Challenges
  4. 2.4 Alzheimer’s Therapeutic Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Alzheimer’s Therapeutic Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Alzheimer’s Therapeutic Revenue by Region
  3. 3.2.1 Global Alzheimer’s Therapeutic Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alzheimer’s Therapeutic Revenue by Region (2021-2026)
  5. 3.2.3 Global Alzheimer’s Therapeutic Revenue by Region (2027-2032)
  6. 3.2.4 Global Alzheimer’s Therapeutic Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Alzheimer’s Therapeutic Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Alzheimer’s Therapeutic Sales by Region
  9. 3.4.1 Global Alzheimer’s Therapeutic Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Alzheimer’s Therapeutic Sales by Region (2021-2026)
  11. 3.4.3 Global Alzheimer’s Therapeutic Sales by Region (2027-2032)
  12. 3.4.4 Global Alzheimer’s Therapeutic Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Alzheimer’s Therapeutic Revenue by Manufacturers
  2. 4.1.1 Global Alzheimer’s Therapeutic Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Alzheimer’s Therapeutic Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Alzheimer’s Therapeutic Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alzheimer’s Therapeutic Sales by Manufacturers
  6. 4.2.1 Global Alzheimer’s Therapeutic Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Alzheimer’s Therapeutic Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Alzheimer’s Therapeutic Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Alzheimer’s Therapeutic Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Alzheimer’s Therapeutic Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Alzheimer’s Therapeutic Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Alzheimer’s Therapeutic Manufacturers, Product Type & Application
  13. 4.7 Global Alzheimer’s Therapeutic Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Alzheimer’s Therapeutic Market CR5 and HHI
  16. 4.8.2 2025 Alzheimer’s Therapeutic Tier 1, Tier 2, and Tier 3
5 Alzheimer’s Therapeutic Market by Type
  1. 5.1 Global Alzheimer’s Therapeutic Revenue by Type
  2. 5.1.1 Global Alzheimer’s Therapeutic Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Alzheimer’s Therapeutic Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Alzheimer’s Therapeutic Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Alzheimer’s Therapeutic Sales by Type
  6. 5.2.1 Global Alzheimer’s Therapeutic Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alzheimer’s Therapeutic Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Alzheimer’s Therapeutic Sales Market Share by Type (2021-2032)
  9. 5.3 Global Alzheimer’s Therapeutic Price by Type
6 Alzheimer’s Therapeutic Market by Application
  1. 6.1 Global Alzheimer’s Therapeutic Revenue by Application
  2. 6.1.1 Global Alzheimer’s Therapeutic Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Alzheimer’s Therapeutic Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Alzheimer’s Therapeutic Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Alzheimer’s Therapeutic Sales by Application
  6. 6.2.1 Global Alzheimer’s Therapeutic Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Alzheimer’s Therapeutic Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Alzheimer’s Therapeutic Sales Market Share by Application (2021-2032)
  9. 6.3 Global Alzheimer’s Therapeutic Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Company Ltd
  2. 7.1.1 Takeda Pharmaceutical Company Ltd Company Information
  3. 7.1.2 Takeda Pharmaceutical Company Ltd Business Overview
  4. 7.1.3 Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Company Ltd Recent Developments
  7. 7.2 Merck & Co
  8. 7.2.1 Merck & Co Company Information
  9. 7.2.2 Merck & Co Business Overview
  10. 7.2.3 Merck & Co Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co Alzheimer’s Therapeutic Product Portfolio
  12. 7.2.5 Merck & Co Recent Developments
  13. 7.3 F. Hoffman Le Roche
  14. 7.3.1 F. Hoffman Le Roche Company Information
  15. 7.3.2 F. Hoffman Le Roche Business Overview
  16. 7.3.3 F. Hoffman Le Roche Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 F. Hoffman Le Roche Alzheimer’s Therapeutic Product Portfolio
  18. 7.3.5 F. Hoffman Le Roche Recent Developments
  19. 7.4 Eli Lilly, Inc
  20. 7.4.1 Eli Lilly, Inc Company Information
  21. 7.4.2 Eli Lilly, Inc Business Overview
  22. 7.4.3 Eli Lilly, Inc Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly, Inc Alzheimer’s Therapeutic Product Portfolio
  24. 7.4.5 Eli Lilly, Inc Recent Developments
  25. 7.5 Pfizer Inc
  26. 7.5.1 Pfizer Inc Company Information
  27. 7.5.2 Pfizer Inc Business Overview
  28. 7.5.3 Pfizer Inc Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Inc Alzheimer’s Therapeutic Product Portfolio
  30. 7.5.5 Pfizer Inc Recent Developments
  31. 7.6 Novartis International AG
  32. 7.6.1 Novartis International AG Company Information
  33. 7.6.2 Novartis International AG Business Overview
  34. 7.6.3 Novartis International AG Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novartis International AG Alzheimer’s Therapeutic Product Portfolio
  36. 7.6.5 Novartis International AG Recent Developments
  37. 7.7 H. Lundbeck A/S
  38. 7.7.1 H. Lundbeck A/S Company Information
  39. 7.7.2 H. Lundbeck A/S Business Overview
  40. 7.7.3 H. Lundbeck A/S Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 H. Lundbeck A/S Alzheimer’s Therapeutic Product Portfolio
  42. 7.7.5 H. Lundbeck A/S Recent Developments
  43. 7.8 Biotie Therapies
  44. 7.8.1 Biotie Therapies Company Information
  45. 7.8.2 Biotie Therapies Business Overview
  46. 7.8.3 Biotie Therapies Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biotie Therapies Alzheimer’s Therapeutic Product Portfolio
  48. 7.8.5 Biotie Therapies Recent Developments
  49. 7.9 Axovant Sciences Ltd
  50. 7.9.1 Axovant Sciences Ltd Company Information
  51. 7.9.2 Axovant Sciences Ltd Business Overview
  52. 7.9.3 Axovant Sciences Ltd Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Axovant Sciences Ltd Alzheimer’s Therapeutic Product Portfolio
  54. 7.9.5 Axovant Sciences Ltd Recent Developments
  55. 7.10 Astra Zeneca plc
  56. 7.10.1 Astra Zeneca plc Company Information
  57. 7.10.2 Astra Zeneca plc Business Overview
  58. 7.10.3 Astra Zeneca plc Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Astra Zeneca plc Alzheimer’s Therapeutic Product Portfolio
  60. 7.10.5 Astra Zeneca plc Recent Developments
  61. 7.11 Acadia Pharmaceuticals, Inc
  62. 7.11.1 Acadia Pharmaceuticals, Inc Company Information
  63. 7.11.2 Acadia Pharmaceuticals, Inc Business Overview
  64. 7.11.3 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product Portfolio
  66. 7.11.5 Acadia Pharmaceuticals, Inc Recent Developments
8 North America
  1. 8.1 North America Alzheimer’s Therapeutic Market Size by Type
  2. 8.1.1 North America Alzheimer’s Therapeutic Revenue by Type (2021-2032)
  3. 8.1.2 North America Alzheimer’s Therapeutic Sales by Type (2021-2032)
  4. 8.1.3 North America Alzheimer’s Therapeutic Price by Type (2021-2032)
  5. 8.2 North America Alzheimer’s Therapeutic Market Size by Application
  6. 8.2.1 North America Alzheimer’s Therapeutic Revenue by Application (2021-2032)
  7. 8.2.2 North America Alzheimer’s Therapeutic Sales by Application (2021-2032)
  8. 8.2.3 North America Alzheimer’s Therapeutic Price by Application (2021-2032)
  9. 8.3 North America Alzheimer’s Therapeutic Market Size by Country
  10. 8.3.1 North America Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Alzheimer’s Therapeutic Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Alzheimer’s Therapeutic Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Alzheimer’s Therapeutic Market Size by Type
  2. 9.1.1 Europe Alzheimer’s Therapeutic Revenue by Type (2021-2032)
  3. 9.1.2 Europe Alzheimer’s Therapeutic Sales by Type (2021-2032)
  4. 9.1.3 Europe Alzheimer’s Therapeutic Price by Type (2021-2032)
  5. 9.2 Europe Alzheimer’s Therapeutic Market Size by Application
  6. 9.2.1 Europe Alzheimer’s Therapeutic Revenue by Application (2021-2032)
  7. 9.2.2 Europe Alzheimer’s Therapeutic Sales by Application (2021-2032)
  8. 9.2.3 Europe Alzheimer’s Therapeutic Price by Application (2021-2032)
  9. 9.3 Europe Alzheimer’s Therapeutic Market Size by Country
  10. 9.3.1 Europe Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Alzheimer’s Therapeutic Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Alzheimer’s Therapeutic Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Alzheimer’s Therapeutic Market Size by Type
  2. 10.1.1 China Alzheimer’s Therapeutic Revenue by Type (2021-2032)
  3. 10.1.2 China Alzheimer’s Therapeutic Sales by Type (2021-2032)
  4. 10.1.3 China Alzheimer’s Therapeutic Price by Type (2021-2032)
  5. 10.2 China Alzheimer’s Therapeutic Market Size by Application
  6. 10.2.1 China Alzheimer’s Therapeutic Revenue by Application (2021-2032)
  7. 10.2.2 China Alzheimer’s Therapeutic Sales by Application (2021-2032)
  8. 10.2.3 China Alzheimer’s Therapeutic Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alzheimer’s Therapeutic Market Size by Type
  2. 11.1.1 Asia Alzheimer’s Therapeutic Revenue by Type (2021-2032)
  3. 11.1.2 Asia Alzheimer’s Therapeutic Sales by Type (2021-2032)
  4. 11.1.3 Asia Alzheimer’s Therapeutic Price by Type (2021-2032)
  5. 11.2 Asia Alzheimer’s Therapeutic Market Size by Application
  6. 11.2.1 Asia Alzheimer’s Therapeutic Revenue by Application (2021-2032)
  7. 11.2.2 Asia Alzheimer’s Therapeutic Sales by Application (2021-2032)
  8. 11.2.3 Asia Alzheimer’s Therapeutic Price by Application (2021-2032)
  9. 11.3 Asia Alzheimer’s Therapeutic Market Size by Country
  10. 11.3.1 Asia Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Alzheimer’s Therapeutic Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Alzheimer’s Therapeutic Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alzheimer’s Therapeutic Market Size by Type
  2. 12.1.1 SAMEA Alzheimer’s Therapeutic Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Alzheimer’s Therapeutic Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Alzheimer’s Therapeutic Price by Type (2021-2032)
  5. 12.2 SAMEA Alzheimer’s Therapeutic Market Size by Application
  6. 12.2.1 SAMEA Alzheimer’s Therapeutic Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Alzheimer’s Therapeutic Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Alzheimer’s Therapeutic Price by Application (2021-2032)
  9. 12.3 SAMEA Alzheimer’s Therapeutic Market Size by Country
  10. 12.3.1 SAMEA Alzheimer’s Therapeutic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Alzheimer’s Therapeutic Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Alzheimer’s Therapeutic Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Alzheimer’s Therapeutic Value Chain Analysis
  2. 13.1.1 Alzheimer’s Therapeutic Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Alzheimer’s Therapeutic Production Mode & Process
  6. 13.2 Alzheimer’s Therapeutic Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Alzheimer’s Therapeutic Distributors
  9. 13.2.3 Alzheimer’s Therapeutic Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst